# ü´Ä Voxel-Based Analysis and Clustering of Cardiac Regions in Lung Cancer Patients
Lung cancer is one of the most frequent and deadliest cancers. The **5-year overall survival rate** is approximately **25%**.  
Among these patients, many are diagnosed with **locally advanced stage 3 NSCLC (LA-NSCLC)**, for which **radiation therapy (RT)** is a primary treatment modality.
This project explores the relationship between cardiac radiation dose and 2-year overall survival (OS) in stage 3 LA-NSCLC patients. Using **voxel-wise statistical modeling**, **unsupervised clustering**, and **advanced visualization**, we investigate spatial dose patterns in CT scans to identify regions most associated with survival outcomes.

---
### ‚ö†Ô∏è Problematic

Radiotherapy involves directing high-energy beams at the tumor to:
- **Maximize dose** to cancer cells
- **Minimize dose** to nearby healthy tissue

However, **higher radiation doses** to the tumor area may also affect surrounding structures ‚Äî especially the **heart and large vessels** ‚Äî leading to increased **treatment-related mortality**.  
One key hypothesis is that **RT dose to specific cardiac regions** may be a contributing factor in reduced overall survival.

---

## üß¨ Dataset Description

- **Source:** IRCCS Istituto Nazionale dei Tumori di Milano  
- **Patients:** 321 cases across 5 centers  
- **Modalities:** DICOM CT scans + RT dose maps  
- **Features:** Clinical, anatomical, therapy, comorbidity, outcome (2-year OS)
- **Data types:** DICOM CT scans, dose distributions, and 54 patient-level features, grouped as follows:

### üîπ Anatomic and Metabolic Features
- Age, sex, height, weight, BMI
- Hypertension, KPS (Karnofsky Performance Status)
- Smoking status
- Medications
- Clinical parameters

### üîπ Cancer-Related Features
- Stage of cancer
- Genetic mutations
- Tumor dimensions
- Site of primary tumor

### üîπ Drug and Therapy Features
- Chemotherapy cycles
- Immunotherapy status
- Start time of RT
- Type of RT machine used
- EQD2 prescription dose
- Volume targeted by RT

### üîπ Disease and Outcome Features
- Overall survival at 2 years
- Pulmonary events
- Cardiac events post-radiotherapy

---

## üß™ Feature Engineering & Preprocessing

- **Medications**: Combined into categories  
  `Diabetes`, `Antilipidic`, `Beta-Blockers`, `Diuretics`, `Antithrombotic`, `Hypertension`  
  ‚Üí Coded as: `0`, `1`, `2`, `>3` (total count)

- **Therapy Types**:  
  `Target Therapy + Immunotherapy (combined)`  
  `Others_pb = Mediastino + N (combined)`

- **Smoking Status**:  
  Binary encoded

- **KPS (Performance Status)**:  
  Grouped into three classes: `<=80`, `90`, `100`

- **Chemotherapy Schedule**:  
  Rescaled, with `0` indicating "no chemotherapy"

---

## üß™ Statistical Tools Used

- Welch‚Äôs t-test (voxel-wise analysis)
- Benjamini‚ÄìHochberg FDR correction
- PCA & DBSCAN for outlier detection
- Mean dose voxel mapping

---


## üß† Methodology Overview

<img src="visuals/pipeline.gif" width="100%" alt="Pipeline Overview"/>

This project follows a multi-stage analytical pipeline:
1. **Preprocessing** of DICOM/CT data
2. **Voxel-Based Analysis (VBA)** for statistical modeling
3. **Unsupervised Clustering** to identify spatial dose patterns
4. **Statistical Significance Testing** (e.g., Welch‚Äôs t-test, FDR correction)
5. **Visualization** of results for interpretation

---
## üß† Analysis Workflow

<img src="photo_2025-07-23_21-43-43.jpg" alt="Voxel Analysis Pipeline" width="700%"/>

This diagram illustrates the full pipeline:
- **Input**: Patient CT scans and dose maps
- **Deformation Step**: All patient data is mapped to a common anatomical template
- **Statistical Analysis**: Voxel-wise comparisons between survivor groups
- **Output**: p-value maps indicating regions associated with 2-year survival

---

## üìä Key Visualizations

| Concept | Visualization |
|--------|----------------|
| **Raw Data** | <img src="output.gif" width="500"/> <br> |
| **Dose Distribution Comparison** | <img src="clideo_editor_4eb173ba0818435a8c0e81e1763eefac.gif" width="500"/> <br> A quick animation showing different dose maps among patients. <br> It visually demonstrates the spread and variation of radiation across individuals. |
| **Voxel-Wise Group Dose Characteristics** | <img src="charts.jpg" width="600"/> <br> Boxplots and histograms compare survivors (YES) and non-survivors (NO) for: <br> ‚ñ´Ô∏è % of zero-dose voxels <br> ‚ñ´Ô∏è Mean dose of non-zero voxels <br> üëâ Survivors tend to have more voxels spared and more focused dosing. |
| **Axial Dose Distribution Map** | <img src="heat.jpg" width="600"/> <br> Heatmaps of mean dose across an axial slice: <br> ‚ñ´Ô∏è Left: Right side of heart <br> ‚ñ´Ô∏è Right: Left side of heart <br> Indicates spatial asymmetry in dose distribution. |
| **Cropping by ROI** | <img src="final.jpg" width="600"/> <br> Manual cropping of 3D dose maps using a fixed coordinate window, applied consistently across patients. <br> This prepares the data for spatial analysis using the following radiobiological normalization: <br> <img src="eqd2formula.jpg" width="250"/> <br> ‚ò¢Ô∏è The **EQD‚ÇÇ formula** adjusts physical dose (D) using a **biological weighting factor**, based on the linear-quadratic model with tissue-specific **Œ±/Œ≤** ratios. <br> ‚ñ´Ô∏è Two settings were applied: Œ±/Œ≤ = 2 (for late-responding tissues) and Œ±/Œ≤ = 5 (intermediate case). |
| **Spatial Clustering Result** | <img src="3d.jpg" width="450"/> <br> **3D voxel cluster plot** showing statistically significant regions (colored labels). <br> ‚ñ´Ô∏è Clustering was applied after thresholding voxel-wise p-values <br> ‚ñ´Ô∏è Labels **39, 42, 46, 47** show spatial coherence across the heart region, pointing to potential anatomical biomarkers. |
| **Dose Distribution & Outlier Detection Summary** | <img src="imgonline-com-ua-2to1-iJFJSxPrRf8Ad.jpg" width="700"/> <br> **Histograms of Maximum and Mean Dose per Patient**: Survivors: mean dose ‚âà **1.83**, higher % of zero-dose voxels (**10.46%**) ; Non-survivors: mean dose ‚âà **1.88**, lower % of zero-dose voxels (**5.59%**) Indicates survivors may receive more focused dosing. |

---

## üí° Findings

- Survivors had more **focused** and **precise** dose distributions in heart regions
- Non-survivors showed **broader, less localized** exposure
- No single heart substructure showed consistent significant association across all patients
- Template alignment was crucial for meaningful voxel-wise comparisons

---

## üöÄ Goals

- Improve understanding of **cardiac toxicity** from radiotherapy
- Identify **spatial biomarkers** predictive of survival
- Support **personalized radiotherapy planning**

---

## üèõÔ∏è Supervision

<img src="logo.jpeg" alt="INT Milano Logo" width="100" align="right"/>

> This research was conducted under the mentorship of  
> **Fondazione IRCCS Istituto Nazionale dei Tumori di Milano**, Italy.

---

## üìú Citation & Literature

- McWilliam et al., "Novel Methodology to Investigate the Effect of Radiation Dose to Heart Substructures on Overall Survival", *International Journal of Radiation Oncology*
- T. Rancati et al., ‚ÄúSLiC Algorithm for Spatial Dose Analysis‚Äù, *Journal of the European Society for Radiotherapy and Oncology*

---



